Depression of Oncogenecity by Dephosphorylating and Degrading BCR-ABL

Oncotarget - United States
doi 10.18632/oncotarget.13754
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Protein Kinase CKIIa Interacts With the BCR Moiety of BCR/Abl and Mediates Proliferation of BCR/Abl-Expressing Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

BCR-ABL Tyrosine Kinase

Science-Business eXchange
2012English

SRC Family Kinases Phosphorylate the BCR-Abl SH3-SH2 Region and Modulate BCR-Abl Transforming Activity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Critical Role for Gab2 in Transformation by BCR/ABL

Cancer Cell
Cancer ResearchOncologyCell Biology
2002English

Disruption of the BCR-Abl/Hsp90 Protein Complex: A Possible Mechanism to Inhibit BCR-Abl-Positive Human Leukemic Blasts by Novobiocin

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Kinase Domain Mutants of BCR Enhance BCR-Abl Oncogenic Effects

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

MT1-MMP as a Downstream Target of BCR-ABL/ABL Interactor 1 Signaling: Polarized Distribution and Involvement in BCR-ABL-stimulated Leukemic Cell Migration

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Bcr: A Negative Regulator of the BCR-Abl Oncoprotein in Leukemia

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

BCR-ABL Affects STAT5A and STAT5B Differentially

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy